Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Jan 3, 2019Alpha radiation startup eliminates 70% of cancerous tumors#CancerBuster Now going into clinical trials for specific types of cancer, Alpha Tau’s technology shows potential for treating any solid...